Makker, Vicky; Pérez-Fidalgo, José-Alejandro; Valabrega, Giorgio; Hamilton, Erika; Van-Gorp, Toon; Sehouli, Jalid; Reginacova, Klaudia; Richardson, Debra-L; Perri, Tamar; Oza, Amit-M; Miller, David-S; Guerra-Alia, Eva-María; de-Giorgi, Ugo; Henry, Stephanie; Spitz, Daniel-L; Wimberger, Pauline; Bednarikova, Marketa; Chon, Hye-Sook; Martínez-García, Jerónimo; Pisano, Carmela; Berek, Jonathan-S; Romero, Ignacio; Scambia, Giovanni; Farinas-Madrid, Lorena; Buscema, Joseph; Schochter, Fabienne; Li, Kai; Kalyanapu, Pratheek; Walker, Christopher-J; Vergote, Ignace
(ACADEMIC PRESS INC ELSEVIER SCIENCE, 2024-06)
OBJECTIVE: To report long-term efficacy and safety of selinexor maintenance therapy in adults with TP53 wild-type (TP53wt) stage IV or recurrent endometrial cancer (EC) who achieved partial remission (PR) or complete ...